title: A cure for the high cost of hepatitis C virus treatment.
authors.forename: Ohad
authors.initials: O
authors.lastname: Etzion
authors.forename: Marc G
authors.initials: MG
authors.lastname: Ghany
mesh_terms: D000998:Antiviral Agents / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D014542:Uridine Monophosphate / Q000031:analogs & derivatives*
chemical_list: D000998:Antiviral Agents; D014542:Uridine Monophosphate
references.citation: Lancet. 2012 Dec 15;380(9859):2095-128
references.pmid: 23245604
references.citation: N Engl J Med. 2013 May 16;368(20):1859-61
references.pmid: 23675657
references.citation: JAMA. 2012 Dec 26;308(24):2584-93
references.pmid: 23268517
references.citation: N Engl J Med. 2014 May 22;370(21):2043-7
references.pmid: 24795199
references.citation: Ann Intern Med. 2015 May 5;162(9):619-29
references.pmid: 25820703
references.citation: Med Lett Drugs Ther. 2014 Jan 20;56(1434):5-6
references.pmid: 24457562
references.citation: Ann Intern Med. 2015 Mar 17;162(6):407-19
references.pmid: 25775313
references.citation: Ann Intern Med. 2015 Mar 17;162(6):397-406
references.pmid: 25775312